Community unites to raise funds, advance research, support
patients affected by nation’s deadliest major cancer
MIAMI–(BUSINESS WIRE)–#PurpleStride–For the third consecutive year, the five-year survival rate for
pancreatic cancer increased and is now nine
percent. However, the disease remains one of the nation’s deadliest.
The Miami Affiliate of the Pancreatic
Cancer Action Network invites the community to change the course of
the disease and improve patient outcomes by attending PurpleStride Miami
2017 presented by Sylvester Comprehensive Cancer Center on Sat., Feb.
11, at Tropical Park.
The Pancreatic Cancer Action Network (PanCAN) is the global leader in
the fight against pancreatic cancer with an urgent mission to improve
outcomes for patients battling the disease today and double patient
survival by 2020. PurpleStride events support this critical work and the
organization’s key initiatives, including Precision
Your Tumor and the Patient
“I lost my brother, Gerry, to pancreatic cancer. He was 59 years old and
died 11 months after diagnosis,” said Anita Marks, PurpleStride Co-Chair
of the Miami Affiliate of the Pancreatic Cancer Action Network.
“PurpleStride Miami allows me to work harder to raise funds and
awareness for this horrible disease. I not only participate in memory of
my brother, but for everyone fighting the fight, and the ones who have
lost — they are all my heroes.”
PurpleStride Miami, hosted by veteran TV news journalist Vickie
Frazier-Williams, includes kid-friendly activities including a purple
play zone and live entertainment. The Miami event is supported by
national presenting sponsor Celgene,
gold sponsor Barry Katz and Sandra James Charitable Foundation, gold
media sponsor NBC
6 and bronze sponsor Community Medical Group.
To register, donate or learn more about PurpleStride Miami, please visit www.purplestride.org/miami.
Watch the PurpleStride PSA here
and the Pancreatic Cancer Action Network’s organizational PSA here.
About the Pancreatic Cancer Action Network
The Pancreatic Cancer Action Network (PanCAN) is the global leader
accelerating the pace of research progress for one of the world’s
deadliest cancers. With an urgent mission to improve outcomes for
pancreatic cancer patients and double survival by 2020, the
organization, founded in 1999, executes a bold and comprehensive
strategy to Wage Hope through research, patient services, advocacy and
community engagement. The organization’s visionary goals, world-class
programs and services, extensive grassroots network, patient-focused
outcomes and advisory board of scientific and medical leaders, provide
the critical backdrop to help pancreatic cancer patients today and
create transformational change for all patients in the future.
Pancreatic Cancer Action Network